Cancer Immunotherapy Winter School

Feb. 22–24, 2021 • Virtual Program
Download program flyer
Meeting Code of Conduct

OVERVIEW

The Society for Immunotherapy of Cancer (SITC) hosted its third annual Cancer Immunotherapy Winter School, a comprehensive cancer immunotherapy education program, virtually on Feb. 22–24, 2021. Taught by leading experts in the field, this program provided a deep understanding of the core principles of tumor immunology and cancer immunotherapy as well as developing areas in the field including biomarker technology, validation and clinical integration; clinical trial design, data analysis and considerations for combination therapies.

The program was tailored to early-to-mid career scientists and clinicians in the field of cancer immunotherapy working in academic, clinical, industry and government settings as well as those new to the field. The curriculum covers the fundamentals of cancer immunotherapy and features separate tracks, including clinical and research, allowing participants to tailor their experience by selecting the educational path most relevant to their learning goals.

ORGANIZERS 

• Christian Capitini, MD – University of Wisconsin-Madison
• Leisha A. Emens, MD, PhD – UPMC Hillman Cancer Center
• Daniel Powell, PhD – University of Pennsylvania

Target Audience

• Early-to-mid career scientists in the field of cancer immunotherapy working in academic, clinical, industry and government settings
• Individuals new to the field working in academic, clinical, industry and government settings

NETWORKING OPPORTUNITIES

In addition to deepening their understanding of integral facets of the field of cancer immunotherapy, attendees expanded their professional network, developing new relationships with faculty and other thought leaders in this intimate setting through small group breakout sessions and networking roundtables.

LEARNING OBJECTIVES

Upon completion of the Cancer Immunotherapy Winter School, participants were able to:

• Describe the core principles of tumor immunology and cancer immunotherapy
• Discuss recent advances in biomarker technology, validation and clinical integration
• Explain appropriate clinical trial data analysis methods and best practices in clinical trial design

Travel Awards

To support young investigators and clinicians interested in attending the Cancer Immunotherapy Winter School, SITC accepted applications for travel awards, which will supplement costs for those honored to attend. Those honored with a 2021 Cancer Immunotherapy Winter School travel award include:

Xue Bai, MD — Peking University Cancer Hospital
Amy Cunningham–Bussel, MD, PhD — Brigham and Women's Hospital
Sapana Kadel, PhD — Dana-Farber Cancer Institute
Barbara Ma, MD — New York Presbyterian / Weill Cornel
Filippo Pederzoli, MD — IRCCS Ospedale San Raffaele